Japanese drug maker Otsuka Pharmaceutical agreed to buy California-based Avanir Pharmaceuticals in a deal that values the Nasdaq-traded company at $3.5 billion.
via WSJ.com: US Business http://ift.tt/1zd9vMd
via WSJ.com: US Business http://ift.tt/1zd9vMd
Nessun commento:
Posta un commento